NEU 3.17% $20.86 neuren pharmaceuticals limited

The appointment of Leerink is significant imo. Neuren would not...

  1. 18 Posts.
    lightbulb Created with Sketch. 3
    The appointment of Leerink is significant imo. Neuren would not make this move unless they were getting to late stage licensing/partnering discussions or wanting to make sure they are well placed to consider any takeover offers. Leerink have the expertise and industry relationships to make something happen very quickly (within 6-8 months imo).
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.86
Change
0.640(3.17%)
Mkt cap ! $2.666B
Open High Low Value Volume
$20.45 $21.10 $20.39 $9.299M 447.5K

Buyers (Bids)

No. Vol. Price($)
1 671 $20.85
 

Sellers (Offers)

Price($) Vol. No.
$20.86 262 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.